2m 2m 2m 2m 2m 2m 2m
InflaRx (IFRX)
NASDAQ
$2.06$0.00 (0.00%)
Price as of Jul 14, 2026 7:24 AM EDT- $122.3MMarket Cap
- 130.94%1-Year Change
- BiotechnologyIndustry
InflaRx (IFRX)
$2.06$0.00 (0.00%)
IFRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.06 | ||
Change | +$0.01 (+0.49%) | ||
Open | $2.03 | ||
High | $2.10 | ||
Low | $1.96 | ||
Previous Close | $2.05 | ||
Volume | 1,720,669 | ||
30-Day Average Volume | 1,452,292 | ||
1-Week Change | -2.37% | ||
1-Month Change | 28.75% | ||
1-Year Change | 130.94% | ||
3-Year Change | -52.42% | ||
5-Year Change | -25.90% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $55.2M | ||
Market Cap | $122.3M | ||
Enterprise Value | $106.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue